Cheers! Endpoints News turns 1 today — and we're unwrapping info on a new subscription plan
Today, Endpoints News is one year old. Like any thriving infant, we’ve been growing at a fast pace, outgrowing a hastily crafted christening garment.
Starting from scratch, with just social media and a lot of word of mouth to rely on, web traffic to Endpoints was less than 14,000 visits per week. Today we notch 14,000 per day, with a total of 139,000 unique readers coming to the website in May.
Email subscriptions — the most important metric we track — grew from zilch to 16,000 daily biopharma subscribers drawn to our independent style of journalism. This was a result of organic, word-of-mouth advocacy from our biggest fans. Endpoints’ “open rate”, the percentage of readers who actually open and read the email reports, has never fallen below 40% — far above industry averages and more than double the rate you see at similar publications.